Generate Biomedicines Inc.
GENB | NASDAQ
$13.21
-$1.25 (-8.64%)
At close: Nov 2, 2026, 4:00 PM ET
$14.41
-$0.05 (-0.35%)
Pre-market:
Nov 2, 2026, 9:28 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -128.7M | -61.45M |
Depreciation & Amortization | 6.5M | 3.27M |
Stock-Based Compensation | 8.24M | n/a |
Other Working Capital | -36.91M | -34.41M |
Other Non-Cash Items | 10.74M | 8.44M |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -35.11M | -30.65M |
Operating Cash Flow | -138.33M | -80.39M |
Capital Expenditures | -4.71M | -3.78M |
Cash Acquisitions | 7.5M | 7.5M |
Purchase of Investments | -321.76M | -321.15M |
Sales Maturities Of Investments | 99.85M | 65M |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -219.12M | -252.43M |
Debt Repayment | -2.11M | -1.12M |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | n/a | n/a |
Financial Cash Flow | 370.81M | 371.39M |
Net Cash Flow | 135.36M | 160.58M |
Free Cash Flow | -143.05M | -84.17M |
Adj. Free Cash Flow | -151.28M | -84.17M |
Maintenance CapEx | n/a | n/a |
Growth CapEx | n/a | n/a |
Owner Earnings | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove GENB